Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Operating Expenses | 11,830 | 10,810 | 9,630 | 6,360 | 7,760 |
| Operating Income | -11,830 | -10,810 | -9,630 | -6,360 | -7,760 |
| Other Income | 420 | 550 | 610 | 560 | 1,290 |
| Pre-tax Income | -11,410 | -10,260 | -9,020 | -5,800 | -6,470 |
| Net Income Continuous | -11,404 | -10,264 | -9,020 | -5,804 | -5,190 |
| Net Income | $-11,404 | $-10,264 | $-9,020 | $-5,804 | $-5,190 |
| EPS Basic Total Ops | -12.37 | -11.14 | -9.72 | -6.36 | -5.66 |
| EPS Basic Continuous Ops | -12.33 | -11.15 | -9.80 | -6.31 | -5.67 |
| EPS Diluted Total Ops | -12.37 | -11.14 | -9.72 | -6.36 | -5.66 |
| EPS Diluted Continuous Ops | -12.33 | -11.15 | -9.80 | -6.02 | -5.43 |
| EBITDA(a) | $-12,310 | $-10,360 | $-9,380 | $-6,090 | $-7,610 |